A detailed history of Bayforest Capital LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Bayforest Capital LTD holds 409 shares of JNJ stock, worth $78,577. This represents 0.03% of its overall portfolio holdings.

Number of Shares
409
Previous 4,148 90.14%
Holding current value
$78,577
Previous $688 Million 90.92%
% of portfolio
0.03%
Previous 0.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025

SELL
$146.36 - $159.82 $547,240 - $597,566
-3,739 Reduced 90.14%
409 $62.5 Million
Q1 2025

May 08, 2025

BUY
$142.06 - $167.7 $437,828 - $516,851
3,082 Added 289.12%
4,148 $379 Million
Q4 2024

Feb 14, 2025

BUY
$143.34 - $165.86 $152,800 - $176,806
1,066 New
1,066 $154 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $502B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bayforest Capital LTD Portfolio

Follow Bayforest Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayforest Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bayforest Capital LTD with notifications on news.